Free Webex Call
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
1 of 3
“The Global Pathogen Reduction Systems Market is Anticipated to a Staggering CAGR of Around 20% During 2021-2025.”
FEATURED COMPANIES
- AngioDynamics, Inc.
- Cerus Corporation
- Macopharma SA
- Octapharma AG
- Terumo BCT, Inc.
- MORE
The Global Pathogen Reduction Systems Market is anticipated to a staggering CAGR of around 20% during 2021-2025. The risk factor related to use of these systems is very less and hence, they are widely being adopted by medical professionals for platelet and plasma reduction from blood donors. Additionally, increasing prevalence of infectious diseases and rising public awareness towards better healthcare facilities coupled with adoption of advanced technologies resulting in improved and more effective pathogen reduction systems, is driving the market across the globe.
Pathogen reduction systems are used to inactivate viruses and bacteria that may contaminate blood products. The system exposes the plasma to ultraviolet rays in presence of photosensitizer thereby acting as pathogen inactivator. These are advanced products and are used in management of blood transfusion and pathogen inactivation. The recent outbreak of COVID-19 is also expected to drive the demand for these systems in the coming years.
The Global Pathogen Reduction Systems Market can be segmented based on type, application, product, end-user and region. Based on application, the market is segmented into viruses, fungi and bacteria. The bacteria segment currently dominates the market owing to the high prevalence of bacterial contamination in blood cells of a patient. However, the virus segment is expected to undergo high growth during the forecast period due to the outbreak of COVID-19, which has turned into a global epidemic.
Based on region, Europe dominates the Global Pathogen Reduction Systems Market as countries like France, Italy, Germany, United Kingdom and Spain have world class healthcare facilities with a large number of trained professions. However, Asia-Pacific is anticipated to emerge as the fastest growing market for pathogen reduction systems industry as countries like China and Japan have presence of manufacturing facilities, which makes them ideal for the growth of pathogen reduction systems market.
Major companies operating in the Global Pathogen Reduction Systems Market include Terumo BCT, Inc., Macopharma SA, Cerus Corporation, AngioDynamics, Inc., Octapharma AG., among others. The manufacturers are adhering to higher safety protocols for the pathogen reduction in the blood to avoid any risk factors.
Years considered for this report:
The author calculated the Global Pathogen Reduction Systems Market by size using a bottom-up approach, where data for various end-user industries and its application across various product types were recorded and forecast for the future years. The author sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used.
Key Target Audience:
Report Scope:
In this report, the Global Pathogen Reduction Systems Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Pathogen Reduction Systems Market, By Type:
Company Profiles: Detailed analysis of the major companies present in the Global Pathogen Reduction Systems Market.
Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.
Pathogen reduction systems are used to inactivate viruses and bacteria that may contaminate blood products. The system exposes the plasma to ultraviolet rays in presence of photosensitizer thereby acting as pathogen inactivator. These are advanced products and are used in management of blood transfusion and pathogen inactivation. The recent outbreak of COVID-19 is also expected to drive the demand for these systems in the coming years.
The Global Pathogen Reduction Systems Market can be segmented based on type, application, product, end-user and region. Based on application, the market is segmented into viruses, fungi and bacteria. The bacteria segment currently dominates the market owing to the high prevalence of bacterial contamination in blood cells of a patient. However, the virus segment is expected to undergo high growth during the forecast period due to the outbreak of COVID-19, which has turned into a global epidemic.
Based on region, Europe dominates the Global Pathogen Reduction Systems Market as countries like France, Italy, Germany, United Kingdom and Spain have world class healthcare facilities with a large number of trained professions. However, Asia-Pacific is anticipated to emerge as the fastest growing market for pathogen reduction systems industry as countries like China and Japan have presence of manufacturing facilities, which makes them ideal for the growth of pathogen reduction systems market.
Major companies operating in the Global Pathogen Reduction Systems Market include Terumo BCT, Inc., Macopharma SA, Cerus Corporation, AngioDynamics, Inc., Octapharma AG., among others. The manufacturers are adhering to higher safety protocols for the pathogen reduction in the blood to avoid any risk factors.
Years considered for this report:
- Historical Years: 2015-2018
- Base Year: 2019
- Estimated Year: 2020
- Forecast Period: 2021–2025
- To analyse and forecast the market size of the Global Pathogen Reduction Systems Market.
- To forecast the Global Pathogen Reduction Systems Market based on type, application, product, end-user and regional distribution.
- To identify drivers and challenges for the Global Pathogen Reduction Systems Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in the Global Pathogen Reduction Systems Market.
- To identify and analyze the profile of leading players operating in the Global Pathogen Reduction Systems Market.
The author calculated the Global Pathogen Reduction Systems Market by size using a bottom-up approach, where data for various end-user industries and its application across various product types were recorded and forecast for the future years. The author sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used.
Key Target Audience:
- Pathogen reduction systems manufacturers, vendors and other stakeholders
- Hospitals/Diagnostic Centres/Blood Banks
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to pathogen reduction systems
- Market research and consulting firms
Report Scope:
In this report, the Global Pathogen Reduction Systems Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Pathogen Reduction Systems Market, By Type:
- Platelet Pathogen Reduction
- Plasma Pathogen Reduction
- Viruses
- Fungi
- Bacteria
- Automated
- Semi-Automated
- Hospitals
- ASCs
- Blood Banks
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Switzerland
- North America
- United States
- Mexico
- Canada
- Rest of World
- Saudi Arabia
- UAE
- Kuwait
- Brazil
Company Profiles: Detailed analysis of the major companies present in the Global Pathogen Reduction Systems Market.
Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.
Note: Product cover images may vary from those shown
2 of 3
FEATURED COMPANIES
- AngioDynamics, Inc.
- Cerus Corporation
- Macopharma SA
- Octapharma AG
- Terumo BCT, Inc.
- MORE
1. Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Pathogen Reduction Systems Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.1.2. By Volume
5.2. Market Share & Forecast
5.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
5.2.2. By Application (Viruses, Fungi, Bacteria)
5.2.3. By Product (Automated, Semi-Automated)
5.2.4. By End User (Hospitals, ASCs, Blood Banks)
5.2.5. By Company (2019)
5.2.6. By Region (Asia-Pacific, Europe, North America, Rest of World)
5.3. Market Attractiveness Index
6. Asia-Pacific Pathogen Reduction Systems Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.1.2. By Volume
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Product
6.2.4. By End User
6.2.5. By Country (China, India, Japan, South Korea, Singapore, Australia)
6.3. Asia-Pacific: Country Analysis
6.3.1. China Pathogen Reduction Systems Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.1.2. By Volume
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By Product
6.3.1.2.4. By End User
6.3.2. India Pathogen Reduction Systems Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.1.2. By Volume
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By Product
6.3.2.2.4. By End Use
6.3.3. Japan Pathogen Reduction Systems Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.1.2. By Volume
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By Product
6.3.3.2.4. By End User
6.3.4. South Korea Pathogen Reduction Systems Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.1.2. By Volume
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Application
6.3.4.2.3. By Product
6.3.4.2.4. By End User
6.3.5. Singapore Pathogen Reduction Systems Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.1.2. By Volume
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Application
6.3.5.2.3. By Product
6.3.5.2.4. By End User
6.3.6. Australia Pathogen Reduction Systems Market Outlook
6.3.6.1. Market Size & Forecast
6.3.6.1.1. By Value
6.3.6.1.2. By Volume
6.3.6.2. Market Share & Forecast
6.3.6.2.1. By Type
6.3.6.2.2. By Application
6.3.6.2.3. By Product
6.3.6.2.4. By End User
7. Europe Pathogen Reduction Systems Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.1.2. By Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Product
7.2.4. By End User
7.2.5. By Country (France, Germany, United Kingdom, Italy, Spain, Switzerland)
7.3. Europe: Country Analysis
7.3.1. France Pathogen Reduction Systems Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.1.2. By Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By Product
7.3.1.2.4. By End User
7.3.2. Germany Pathogen Reduction Systems Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.1.2. By Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By Product
7.3.2.2.4. By End User
7.3.3. United Kingdom Pathogen Reduction Systems Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.1.2. By Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By Product
7.3.3.2.4. By End User
7.3.4. Italy Pathogen Reduction Systems Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.1.2. By Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By Product
7.3.4.2.4. By End User
7.3.5. Spain Pathogen Reduction Systems Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.1.2. By Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By Product
7.3.5.2.4. By End User
7.3.6. Switzerland Pathogen Reduction Systems Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.1.2. By Volume
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Type
7.3.6.2.2. By Application
7.3.6.2.3. By Product
7.3.6.2.4. By End User
8. North America Pathogen Reduction Systems Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.1.2. By Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Product
8.2.4. By End User
8.2.5. By Country (United States, Mexico, Canada)
8.3. North America: Country Analysis
8.3.1. United States Pathogen Reduction Systems Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.1.2. By Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By Product
8.3.1.2.4. By End User
8.3.2. Mexico Pathogen Reduction Systems Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.1.2. By Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By Product
8.3.2.2.4. By End User
8.3.3. Canada Pathogen Reduction Systems Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.1.2. By Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By Product
8.3.3.2.4. By End User
9. Rest of World Pathogen Reduction Systems Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.1.2. By Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Product
9.2.4. By End User
9.2.5. By Country (Saudi Arabia, UAE, Kuwait, Brazil)
9.3. Rest of World: Country Analysis
9.3.1. Saudi Arabia Pathogen Reduction Systems Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.1.2. By Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By Product
9.3.1.2.4. By End User
9.3.2. UAE Pathogen Reduction Systems Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.1.2. By Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By Product
9.3.2.2.4. By End User
9.3.3. Kuwait Pathogen Reduction Systems Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.1.2. By Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By Product
9.3.3.2.4. By End User
9.3.4. Brazil Pathogen Reduction Systems Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.1.2. By Volume
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Application
9.3.4.2.3. By Product
9.3.4.2.4. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Competitive Landscape
12.1. Terumo BCT, Inc.
12.2. Macopharma SA
12.3. Cerus Corporation
12.4. AngioDynamics, Inc.
12.5. Octapharma AG
13. Strategic Recommendations
List of Figures
Figure 1: Global Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Thousand Units) 2015-2025F
Figure 2: Global Healthcare Spending, By Region, By Value, 2019 (USD Billion)
Figure 3: Global Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 4: Global Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 5: Global Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 6: Global Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 7: Global Pathogen Reduction Systems Market Share, By Region, By Value, 2020E & 2025F
Figure 8: Global Pathogen Reduction Systems Market Share, By Company, By Value, 2019
Figure 9: Type Map on the basis of Market Size (USD Million) & Growth Rate (%)
Figure 10: Region Map on the basis of Market Size (USD Million) & Growth Rate (%)
Figure 11: Europe Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Thousand Units) 2015-2025F
Figure 12: Number of Blood Donations in Europe, By Country, By Value (No. of Persons), 2017-2018
Figure 13: Europe Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 14: Europe Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 15: Europe Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 16: Europe Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 17: Europe Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 18: France Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 19: France Number of Covid-19 Cases, By Value, Feb 2020 - May 2020
Figure 20: France Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 21: France Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 22: France Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 23: France Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 24: Germany Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 25: Germany Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 26: Germany Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 27: Germany Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 28: Germany Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 29: Spain Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 30: Spain Healthcare Spending, By Value (USD Per Capita), 2015-2018
Figure 31: Spain Covid-19 Cumulative Statistics, By Value, Till 13 May 2020
Figure 32: Spain Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 33: Spain Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 34: Spain Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 35: Spain Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 36: United Kingdom Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 37: United Kingdom Healthcare Spending, By Value (USD Per Capita), 2015-2018
Figure 38: United Kingdom Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 39: United Kingdom Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 40: United Kingdom Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 41: United Kingdom Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 42: Italy Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 43: Italy Covid-19 Cumulative Statistics, By Value, Till 13 May 2020
Figure 44: Italy Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 45: Italy Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 46: Italy Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 47: Italy Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 48: Switzerland Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 49: Switzerland Blood Transfusion Statistics Share, By Units 2019, (In Nos)
Figure 50: Switzerland Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 51: Switzerland Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 52: Switzerland Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 53: Switzerland Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 54: North America Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Units) 2015-2025F
Figure 55: North America Health Spending Share, By Value, 2020E
Figure 56: North America Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 57: North America Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 58: North America Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 59: North America Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 60: North America Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 61: United States Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 62: United States Healthcare Spending, By Value, 2018 -2021F (USD Per Capita)
Figure 63: United States Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 64: United States Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 65: United States Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 66: United States Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 67: Canada Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 68: Canada Covid-19 Cumulative Statistics, By Value, Till 26th May 2020
Figure 69: Canada Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 70: Canada Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 71: Canada Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 72: Canada Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 73: Canada Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 74: Mexico Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 75: Mexico Covid-19 Cumulative Statistics, By Value, Till 26th May 2020
Figure 76: Mexico Pharmaceutical Products Market Size, By Value, 2019 – 2022F (USD Billion)
Figure 77: Mexico Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 78: Mexico Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 79: Mexico Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 80: Mexico Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 81: Asia-Pacific Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Units) 2015-2025F
Figure 82: Asia-Pacific Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 83: Asia-Pacific Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 84: Asia-Pacific Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 85: Asia-Pacific Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 86: Asia-Pacific Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 87: Japan Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 88: Japan Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 89: Japan Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 90: Japan Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 91: Japan Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 92: China Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 93: Number of Voluntary Blood Donations in China, By Value (Million), 2017 & 2018
Figure 94: China Covid-19 Cumulative Statistics, By Value, Till 14th May 2020
Figure 95: China Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 96: China Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 97: China Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 98: China Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 99: Australia Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 100: Australia Enterprise Healthcare Spending, By Value (USD Billion) 2017-2021E
Figure 101: Australia Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 102: Australia Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 103: Australia Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 104: Australia Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 105: South Korea Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 106: South Korea Blood Supply for Transfusion and Fractionation, 2019 (In Units)
Figure 107: South Korea Covid-19 Test Performed Statistics, By Share, Till 14th May 2020
Figure 108: South Korea Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 109: South Korea Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 110: South Korea Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 111: South Korea Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 112: Singapore Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 113: Singapore Blood Utilization Share, By Application, By Volume, 2018
Figure 114: Singapore Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 115: Singapore Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 116: Singapore Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 117: Singapore Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 118: India Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 119: Blood Components Demand in India, By Value (In No.), 2017
Figure 120: India Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 121: India Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 122: India Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 123: India Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 124: Rest of World Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Units) 2015-2025F
Figure 125: Rest of World Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 126: Rest of World Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 127: Rest of World Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 128: Rest of World Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 129: Rest of World Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 130: Saudi Arabia Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 131: Saudi Arabia Healthcare Budget, By Value (USD Billion),2018 & 2019
Figure 132: Saudi Arabia Covid-19 Cumulative Statistics, By Value, Till 13th May 2020
Figure 133: Saudi Arabia Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 134: Saudi Arabia Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 135: Saudi Arabia Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 136: Saudi Arabia Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 137: UAE Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 138: UAE Healthcare Expenditure, By Value (USD Billion),2018, 2019, 2023F & 2028F
Figure 139: UAE Covid-19 Cumulative Statistics, By Value, Till 13th May 2020
Figure 140: UAE Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 141: UAE Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 142: UAE Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 143: UAE Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 144: Kuwait Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 145: Kuwait Domestic Population Breakdown, By Age Group, 2019
Figure 146: Kuwait Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 147: Kuwait Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 148: Kuwait Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 149: Kuwait Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 150: Brazil Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 151: Brazil Deaths from H1N1 Influenza, 2012-2021E
Figure 152: Brazil Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 153: Brazil Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 154: Brazil Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 155: Brazil Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Pathogen Reduction Systems Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.1.2. By Volume
5.2. Market Share & Forecast
5.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
5.2.2. By Application (Viruses, Fungi, Bacteria)
5.2.3. By Product (Automated, Semi-Automated)
5.2.4. By End User (Hospitals, ASCs, Blood Banks)
5.2.5. By Company (2019)
5.2.6. By Region (Asia-Pacific, Europe, North America, Rest of World)
5.3. Market Attractiveness Index
6. Asia-Pacific Pathogen Reduction Systems Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.1.2. By Volume
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Product
6.2.4. By End User
6.2.5. By Country (China, India, Japan, South Korea, Singapore, Australia)
6.3. Asia-Pacific: Country Analysis
6.3.1. China Pathogen Reduction Systems Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.1.2. By Volume
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By Product
6.3.1.2.4. By End User
6.3.2. India Pathogen Reduction Systems Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.1.2. By Volume
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By Product
6.3.2.2.4. By End Use
6.3.3. Japan Pathogen Reduction Systems Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.1.2. By Volume
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By Product
6.3.3.2.4. By End User
6.3.4. South Korea Pathogen Reduction Systems Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.1.2. By Volume
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Application
6.3.4.2.3. By Product
6.3.4.2.4. By End User
6.3.5. Singapore Pathogen Reduction Systems Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.1.2. By Volume
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Application
6.3.5.2.3. By Product
6.3.5.2.4. By End User
6.3.6. Australia Pathogen Reduction Systems Market Outlook
6.3.6.1. Market Size & Forecast
6.3.6.1.1. By Value
6.3.6.1.2. By Volume
6.3.6.2. Market Share & Forecast
6.3.6.2.1. By Type
6.3.6.2.2. By Application
6.3.6.2.3. By Product
6.3.6.2.4. By End User
7. Europe Pathogen Reduction Systems Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.1.2. By Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Product
7.2.4. By End User
7.2.5. By Country (France, Germany, United Kingdom, Italy, Spain, Switzerland)
7.3. Europe: Country Analysis
7.3.1. France Pathogen Reduction Systems Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.1.2. By Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By Product
7.3.1.2.4. By End User
7.3.2. Germany Pathogen Reduction Systems Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.1.2. By Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By Product
7.3.2.2.4. By End User
7.3.3. United Kingdom Pathogen Reduction Systems Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.1.2. By Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By Product
7.3.3.2.4. By End User
7.3.4. Italy Pathogen Reduction Systems Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.1.2. By Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By Product
7.3.4.2.4. By End User
7.3.5. Spain Pathogen Reduction Systems Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.1.2. By Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By Product
7.3.5.2.4. By End User
7.3.6. Switzerland Pathogen Reduction Systems Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.1.2. By Volume
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Type
7.3.6.2.2. By Application
7.3.6.2.3. By Product
7.3.6.2.4. By End User
8. North America Pathogen Reduction Systems Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.1.2. By Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Product
8.2.4. By End User
8.2.5. By Country (United States, Mexico, Canada)
8.3. North America: Country Analysis
8.3.1. United States Pathogen Reduction Systems Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.1.2. By Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By Product
8.3.1.2.4. By End User
8.3.2. Mexico Pathogen Reduction Systems Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.1.2. By Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By Product
8.3.2.2.4. By End User
8.3.3. Canada Pathogen Reduction Systems Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.1.2. By Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By Product
8.3.3.2.4. By End User
9. Rest of World Pathogen Reduction Systems Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.1.2. By Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Product
9.2.4. By End User
9.2.5. By Country (Saudi Arabia, UAE, Kuwait, Brazil)
9.3. Rest of World: Country Analysis
9.3.1. Saudi Arabia Pathogen Reduction Systems Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.1.2. By Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By Product
9.3.1.2.4. By End User
9.3.2. UAE Pathogen Reduction Systems Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.1.2. By Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By Product
9.3.2.2.4. By End User
9.3.3. Kuwait Pathogen Reduction Systems Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.1.2. By Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By Product
9.3.3.2.4. By End User
9.3.4. Brazil Pathogen Reduction Systems Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.1.2. By Volume
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Application
9.3.4.2.3. By Product
9.3.4.2.4. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Competitive Landscape
12.1. Terumo BCT, Inc.
12.2. Macopharma SA
12.3. Cerus Corporation
12.4. AngioDynamics, Inc.
12.5. Octapharma AG
13. Strategic Recommendations
List of Figures
Figure 1: Global Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Thousand Units) 2015-2025F
Figure 2: Global Healthcare Spending, By Region, By Value, 2019 (USD Billion)
Figure 3: Global Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 4: Global Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 5: Global Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 6: Global Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 7: Global Pathogen Reduction Systems Market Share, By Region, By Value, 2020E & 2025F
Figure 8: Global Pathogen Reduction Systems Market Share, By Company, By Value, 2019
Figure 9: Type Map on the basis of Market Size (USD Million) & Growth Rate (%)
Figure 10: Region Map on the basis of Market Size (USD Million) & Growth Rate (%)
Figure 11: Europe Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Thousand Units) 2015-2025F
Figure 12: Number of Blood Donations in Europe, By Country, By Value (No. of Persons), 2017-2018
Figure 13: Europe Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 14: Europe Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 15: Europe Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 16: Europe Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 17: Europe Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 18: France Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 19: France Number of Covid-19 Cases, By Value, Feb 2020 - May 2020
Figure 20: France Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 21: France Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 22: France Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 23: France Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 24: Germany Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 25: Germany Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 26: Germany Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 27: Germany Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 28: Germany Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 29: Spain Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 30: Spain Healthcare Spending, By Value (USD Per Capita), 2015-2018
Figure 31: Spain Covid-19 Cumulative Statistics, By Value, Till 13 May 2020
Figure 32: Spain Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 33: Spain Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 34: Spain Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 35: Spain Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 36: United Kingdom Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 37: United Kingdom Healthcare Spending, By Value (USD Per Capita), 2015-2018
Figure 38: United Kingdom Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 39: United Kingdom Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 40: United Kingdom Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 41: United Kingdom Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 42: Italy Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 43: Italy Covid-19 Cumulative Statistics, By Value, Till 13 May 2020
Figure 44: Italy Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 45: Italy Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 46: Italy Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 47: Italy Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 48: Switzerland Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 49: Switzerland Blood Transfusion Statistics Share, By Units 2019, (In Nos)
Figure 50: Switzerland Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 51: Switzerland Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 52: Switzerland Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 53: Switzerland Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 54: North America Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Units) 2015-2025F
Figure 55: North America Health Spending Share, By Value, 2020E
Figure 56: North America Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 57: North America Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 58: North America Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 59: North America Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 60: North America Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 61: United States Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 62: United States Healthcare Spending, By Value, 2018 -2021F (USD Per Capita)
Figure 63: United States Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 64: United States Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 65: United States Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 66: United States Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 67: Canada Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 68: Canada Covid-19 Cumulative Statistics, By Value, Till 26th May 2020
Figure 69: Canada Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 70: Canada Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 71: Canada Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 72: Canada Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 73: Canada Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 74: Mexico Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 75: Mexico Covid-19 Cumulative Statistics, By Value, Till 26th May 2020
Figure 76: Mexico Pharmaceutical Products Market Size, By Value, 2019 – 2022F (USD Billion)
Figure 77: Mexico Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 78: Mexico Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 79: Mexico Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 80: Mexico Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 81: Asia-Pacific Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Units) 2015-2025F
Figure 82: Asia-Pacific Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 83: Asia-Pacific Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 84: Asia-Pacific Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 85: Asia-Pacific Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 86: Asia-Pacific Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 87: Japan Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 88: Japan Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 89: Japan Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 90: Japan Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 91: Japan Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 92: China Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 93: Number of Voluntary Blood Donations in China, By Value (Million), 2017 & 2018
Figure 94: China Covid-19 Cumulative Statistics, By Value, Till 14th May 2020
Figure 95: China Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 96: China Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 97: China Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 98: China Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 99: Australia Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 100: Australia Enterprise Healthcare Spending, By Value (USD Billion) 2017-2021E
Figure 101: Australia Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 102: Australia Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 103: Australia Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 104: Australia Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 105: South Korea Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 106: South Korea Blood Supply for Transfusion and Fractionation, 2019 (In Units)
Figure 107: South Korea Covid-19 Test Performed Statistics, By Share, Till 14th May 2020
Figure 108: South Korea Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 109: South Korea Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 110: South Korea Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 111: South Korea Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 112: Singapore Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 113: Singapore Blood Utilization Share, By Application, By Volume, 2018
Figure 114: Singapore Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 115: Singapore Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 116: Singapore Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 117: Singapore Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 118: India Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 119: Blood Components Demand in India, By Value (In No.), 2017
Figure 120: India Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 121: India Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 122: India Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 123: India Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 124: Rest of World Pathogen Reduction Systems Market Size, By Value (USD Million), By Volume (Units) 2015-2025F
Figure 125: Rest of World Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 126: Rest of World Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 127: Rest of World Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 128: Rest of World Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 129: Rest of World Pathogen Reduction Systems Market Share, By Country, By Value, 2019 & 2025F
Figure 130: Saudi Arabia Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 131: Saudi Arabia Healthcare Budget, By Value (USD Billion),2018 & 2019
Figure 132: Saudi Arabia Covid-19 Cumulative Statistics, By Value, Till 13th May 2020
Figure 133: Saudi Arabia Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 134: Saudi Arabia Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 135: Saudi Arabia Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 136: Saudi Arabia Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 137: UAE Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 138: UAE Healthcare Expenditure, By Value (USD Billion),2018, 2019, 2023F & 2028F
Figure 139: UAE Covid-19 Cumulative Statistics, By Value, Till 13th May 2020
Figure 140: UAE Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 141: UAE Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 142: UAE Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 143: UAE Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 144: Kuwait Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 145: Kuwait Domestic Population Breakdown, By Age Group, 2019
Figure 146: Kuwait Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 147: Kuwait Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 148: Kuwait Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 149: Kuwait Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Figure 150: Brazil Pathogen Reduction Systems Market Size, By Value (USD Million), 2015–2025F
Figure 151: Brazil Deaths from H1N1 Influenza, 2012-2021E
Figure 152: Brazil Pathogen Reduction Systems Market Share, By Type, By Value, 2015-2025F
Figure 153: Brazil Pathogen Reduction Systems Market Share, By Application, By Value, 2015-2025F
Figure 154: Brazil Pathogen Reduction Systems Market Share, By Product, By Value, 2015-2025F
Figure 155: Brazil Pathogen Reduction Systems Market Share, By End User, By Value, 2015-2025F
Note: Product cover images may vary from those shown
3 of 3
- Terumo BCT, Inc.
- Macopharma SA
- Cerus Corporation
- AngioDynamics, Inc.
- Octapharma AG
Note: Product cover images may vary from those shown
